Saturday, March 2, 2024

CATEGORY

Pharmacoeconomics

Pharmaceutical Giants Respond to FTC Patent System Challenges with Significant Delistings

In response to the Federal Trade Commission's (FTC) November challenge aimed at increasing competition by addressing alleged misuse of the patent system, three pharmaceutical...

Calls for Critical Reform in EU Generic Medicine Procurement Policies to Enhance Supply Security

The necessity for reform in the procurement policies related to generic medicines is imperative to ensure a more secure supply chain for patients and...

New HMA-EMA Catalogs Featuring Real-World Data Sources and Studies Introduced

The launch of new catalogs by the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) represents a significant stride towards enhancing...

What Is Pharmacoeconomics?

What Is Pharmacoeconomics? Pharmacoeconomics is a branch of health economics that focuses on the economic evaluation of pharmaceutical products and services. It involves the application...

Pharmaceutical CEOs Defend High Prices of Drugs in Senate Hearing

CEOs from leading pharmaceutical companies including Johnson & Johnson, Merck, and Bristol Myers Squibb defended the high price of prescription drugs in the U.S....

No Survival Benefit Found for Opioid Overdoses: Reevaluating Naloxone Dosage

A recent study published in the CDC’s Morbidity and Mortality Weekly Report reveals surprising findings regarding the treatment of opioid overdose patients. The study...

Unveiling the Impact of Value-Based Medication Benefits in Diabetes Management

The potential of Value-Based Medication (VBM) Benefits in managing diabetes complications is explored. A significant impact has been found, with an 8.4% reduction in...

Study Reveals Insulin Prices in the US Significantly Exceed Those in Foreign Markets

A recent publication by the Rand Corporation has highlighted the substantial increases in insulin prices in the United States since the early 2010s. Despite...

Legislative Milestones in the US Biotech Sector Boost Innovation in Small Molecule Drugs

The recent passage of two pivotal pieces of legislation in the United States marks a significant advancement in supporting innovation within the small molecule...

DTG-Based HIV Treatment Proves More Cost-Effective than Standard Care

The World Health Organization (WHO) advocates for dolutegravir (DTG), an HIV medication, as the primary and secondary HIV treatment for all populations. This is...

Latest news

Sticky Image